Advertisement
Home »

Suicidal risk associated with finasteride versus dutasteride among men treated for benign prostatic hyperplasia: nationwide cohort study.

Apr 03, 2023

REFERENCES & ADDITIONAL READING

PubMed

ABOUT THE CONTRIBUTORS

  • Moussa Laanani

    Epiphare (French National Medicines Agency ANSM and French National Health Insurance CNAM), Saint-Denis, France. moussa.laanani@assurance-maladie.fr.

    French National Health Insurance (CNAM), Paris, France. moussa.laanani@assurance-maladie.fr.

    Alain Weill

    Epiphare (French National Medicines Agency ANSM and French National Health Insurance CNAM), Saint-Denis, France.

    Fabrice Jollant

    Université Paris-Saclay & CHU Bicêtre, AP-HP, Le Kremlin-Bicêtre, France.

    Nîmes University Hospital (CHU), Nîmes, France.

    Department of psychiatry, McGill Group for Suicide Studies, McGill University, Montréal, Canada.

    Moods Team, INSERM UMR-1018, CESP, Le Kremlin-Bicêtre, France.

    Mahmoud Zureik

    Epiphare (French National Medicines Agency ANSM and French National Health Insurance CNAM), Saint-Denis, France.

    Rosemary Dray-Spira

    Epiphare (French National Medicines Agency ANSM and French National Health Insurance CNAM), Saint-Denis, France.

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


EXPLORE MORE

Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

RELEVANT ARTICLES FOR YOU

Advertisement